Pancreatic Cancer Research

ResearcherUniversity Hospital MünsterNo recent work listed

Andreas Hilbig

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5010615256. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 1 paper

Papers 3

  1. Intensified chemotherapy and simultaneous treatment with heparin in outpatients with pancreatic cancer - the CONKO 004 pilot trial. First author DOI 10.1186/1471-2407-14-204↗
  2. Value of carbohydrate antigen 19-9 in predicting response and therapy control in patients with metastatic pancreatic cancer undergoing first-line therapy. First author DOI 10.3389/fonc.2013.00155↗
  3. Transforming growth factor beta in pancreatic cancer. Co-author DOI 10.2174/138920111798808356↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marcus Bahra · 2 shared papers, 2013–2014 · strength 0.09
  2. Jens Stieler · 2 shared papers, 2013–2014 · strength 0.09
  3. Marianne Sinn · 2 shared papers, 2013–2014 · strength 0.09
  4. Uwe Pelzer · 2 shared papers, 2013–2014 · strength 0.09
  5. Hanno B. Riess · 2 shared papers, 2013–2014 · strength 0.09
  6. Helmut Oettle · 1 shared paper, 2011 · strength 0.06
  7. Bernhard Gebauer · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.